UNITED STATES
                       SECURITIES AND EXCHANGE COMMISSION

                             Washington, D.C. 20549
                                  _____________

                                    Form 8-K

                                 CURRENT REPORT

     Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934

     Date of Report (Date of earliest event reportedly): September 03, 2009


                              OCEAN BIO-CHEM, INC.
               (Exact name of registrant as specified in charter)

        Florida                         0-11102                   59-1564329
(State or Other Jurisdiction    (Commission File Number)      (I.R.S. Employer
     of Incorporation)                                       Identification No.)

               4041 S.W. 47 Avenue, Fort Lauderdale, Florida 33314
                (Address of principal executive office Zip Code)

                                 (954) 587-6280
               Registrant's telephone number, including area code:

                                 Not Applicable
          (Former name or former address, if changes since last report)

     Check the  appropriate  box below if the Form 8-K  filing  is  intended  to
simultaneously  satisfy the filing obligation of the registrant under any of the
following provisions:

     [ ] Written  communications  pursuant to Rule 425 under the  Securities Act
(17 CFR 230.425)

     [ ] Soliciting  material pursuant to Rule 14a-12 under the Exchange Act (17
CFR 240.14a-12)

     [ ]  Pre-commencement  communications  pursuant to Rule 14d-2(b)  under the
Exchange Act (17 CFR 240.14d-2(b))

     [ ]  Pre-commencement  communications  pursuant to Rule 13e-4(c)  under the
Exchange Act (17 CFR 240.13e-4(c))




Item 7.01 Regulation FD

     Ocean  Bio-Chem,   Inc.'s  (OBCI)  wholly  owned  subsidiary,   Star  brite
Distributing,  Inc,.  obtained  an  injunction  in U.S.  Federal  Court  against
ValvTect for false and deceptive  advertising  in their ads  comparing  ValvTect
Ethanol Gas Treatment to Star brite's Star Tron Enzyme Fuel Treatment.

     The U.S. District Court ordered a preliminary  injunction  against ValvTect
from running  further false and  misleading  comparison  advertising of ValvTect
Ethanol  Gasoline  Treatment  and Star brite's Star Tron Enzyme Fuel  Treatment.
Furthermore,  the Court stated that  granting a  "preliminary  injunction  is an
extraordinary and drastic remedy."

     The Court  ruled all four  points of  ValvTect's  comparison  ads are false
and/or misleading and deceived the public.  ValvTect claimed test results proved
their  product  performed  better,  yet the Court found they failed to run their
tests using E10 (Ethanol  fuel),  even though the ads and products are about E10
(Ethanol fuel). ValvTect claimed independent testing, yet the Court found one of
the tests  was run by a  ValvTect  supplier  and was not  independent.  ValvTect
inferred  approvals from major OEMs  including  BMW, Ford and Chrysler,  yet the
Court found there were no such approvals. Every single point of the ValvTect ads
has been found to be false or misleading by the Court.

holder.


                                   SIGNATURES

     Pursuant to the  requirements  of the Securities  Exchange Act of 1934, the
Registrant  has duly  caused  this  report  to be  signed  on its  behalf by the
undersigned thereunto duly authorized.


                                       Ocean Bio-Chem, Inc.
September 03, 2009                     /s/ Jeffrey S. Barocas
                                       Jeffrey S. Barocas
                                       Vice President - Finance and
                                       Chief Financial Officer